Stay updated on Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, Revision: v3.5.3, was added to the Study Record Versions, and the previous Revision: v3.5.2 entry was removed. This updates the visible history to reflect the latest documentation revision.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history now includes a new entry for Revision v3.5.2, and the entry for Revision v3.5.0 was removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe Record History now shows a new revision entry (v3.5.0) and deletes the previous revision (v3.4.3).SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed. The page now includes newly added References and Study Status entries in the Record History.SummaryDifference0.4%

- Check79 days agoChange DetectedRevision v3.4.2 was added to the history, and the funding lapse notice and prior Revision: v3.4.1 were removed as administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check87 days agoChange DetectedA site-wide notice about government funding delays was added and the site version label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.